National Cancer Institute; Notice of Closed Meetings, 12622 [2017-04173]
Download as PDF
12622
Federal Register / Vol. 82, No. 42 / Monday, March 6, 2017 / Notices
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Yisong Wang, Ph.D.,
Scientific Review Officer, NCCIH/NIH, 6707
Democracy Blvd., Suite 401, Bethesda, MD
20817, 301–480–9483, yisong.wang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Integrative Health,
National Institutes of Health, HHS)
Dated: February 28, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04176 Filed 3–3–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications/
contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel,
Quantitative Imaging for Evaluation of
Cancer Therapies (U01).
Date: March 29, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W260, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W260, Bethesda, MD 20892–
9750, 240–276–5856, nadeem.khan@nih.gov.
CBPL No.
27–01
27–05
27–06
27–07
Dated: February 28, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
D
D
D
D
287
4928
473
4807
19:24 Mar 03, 2017
Notice of accreditation and
approval of Inspectorate America
Corporation as a commercial gauger and
laboratory.
ACTION:
Notice is hereby given,
pursuant to CBP regulations, that
Inspectorate America Corporation has
been approved to gauge petroleum and
certain petroleum products and
accredited to test petroleum and certain
petroleum products for customs
purposes for the next three years as of
July 21, 2016.
DATES: The accreditation and approval
of Inspectorate America Corporation as
commercial gauger and laboratory
became effective on July 21, 2016. The
next triennial inspection date will be
scheduled for July 2019.
FOR FURTHER INFORMATION CONTACT:
Approved Gauger and Accredited
Laboratories Manager, Laboratories and
Scientific Services Directorate, U.S.
Customs and Border Protection, 1300
Pennsylvania Avenue NW., Suite
1500N, Washington, DC 20229, tel. 202–
344–1060.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.12
and 19 CFR 151.13, that Inspectorate
America Corporation, 22934 Lockness
Ave, Torrance, CA 90501 has been
approved to gauge petroleum and
certain petroleum products and
accredited to test petroleum and certain
petroleum products for customs
purposes, in accordance with the
provisions of 19 CFR 151.12 and 19 CFR
151.13. Inspectorate America
Corporation is approved for the
following gauging procedures for
petroleum and certain petroleum
products from the American Petroleum
Institute (API):
SUMMARY:
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation and Approval of
Inspectorate America Corporation, as a
Commercial Gauger and Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
AGENCY:
API chapters
Title
3 .......................
7 .......................
8 .......................
12 .....................
17 .....................
[FR Doc. 2017–04173 Filed 3–3–17; 8:45 am]
ASTM
..............
..............
..............
..............
VerDate Sep<11>2014
Name of Committee: National Cancer
Institute Special Emphasis Panel, Digital
Platforms to Support Informal Cancer
Caregiving.
Date: March 30–31, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
4W032/34, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Scott A. Chen, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W526, Bethesda, MD 20892–9750,
240–276–6038, chensc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Biomarkers and Biospecimens.
Date: March 31, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W106, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W106, Rockville, MD 20892–
9750, 240–276–6384, gravesr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Tank Gauging.
Temperature Determination.
Sampling.
Calculations.
Marine Measurement.
Inspectorate America Corporation is
accredited for the following laboratory
analysis procedures and methods for
petroleum and certain petroleum
products set forth by the U.S. Customs
and Border Protection Laboratory
Methods (CBPL) and American Society
for Testing and Materials (ASTM):
Title
Standard
Standard
Standard
Standard
Test
Test
Test
Test
Jkt 241001
Method
Method
Method
Method
PO 00000
for
for
for
for
API Gravity of Crude Petroleum and Petroleum Products (Hydrometer Method).
Water in Crude Oils by Coulometric Karl Fischer Titration.
Sediment in Crude Oils and Fuel Oils by the Extraction Method.
Sediment in Crude Oil by Membrane Filtration.
Frm 00090
Fmt 4703
Sfmt 4703
E:\FR\FM\06MRN1.SGM
06MRN1
Agencies
[Federal Register Volume 82, Number 42 (Monday, March 6, 2017)]
[Notices]
[Page 12622]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04173]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications/contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications/contract
proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Quantitative Imaging for Evaluation of Cancer Therapies
(U01).
Date: March 29, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W260, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856,
nadeem.khan@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Digital Platforms to Support Informal Cancer Caregiving.
Date: March 30-31, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 4W032/34, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Scott A. Chen, Ph.D., Scientific Review Officer,
Program Coordination and Referral Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W526, Bethesda, MD 20892-9750, 240-276-6038,
chensc@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Cancer Biomarkers and Biospecimens.
Date: March 31, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W106, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Reed A. Graves, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W106, Rockville, MD 20892-9750, 240-276-6384,
gravesr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 28, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04173 Filed 3-3-17; 8:45 am]
BILLING CODE 4140-01-P